Showing results (321-330 of 610) with videos related to
Sort By:
Pageof 61
Thrombosis and Haemostasis|December 15, 1986
Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodiesV Darras, M Thienpont, D C Stump, et al.European Journal of Clinical Investigation|June 1, 1978
Turnover of radiolabelled plasminogen and prothrombin in cirrhosis of the liverD Collen, J Rouvier, D A Chamone, et al.Circulation|March 1, 1995
Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamsterJ M Stassen, A Nyström, M Hoylaerts, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosisF Van de Werf, I K Jang, D CollenClinical and Experimental Pharmacology & Physiology|October 27, 2011
Effect of gelatinase inhibition on adipogenesis and adipose tissue developmentM Van Hul, D Bauters, U Himmelreich, et al.Thrombosis Research|November 15, 1984
Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activatorF W Dunn, K Deguchi, J Soria, et al.The Journal of Clinical Investigation|April 1, 1985
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin IIIC Mattsson, M Hoylaerts, E Holmer, et al.Journal of Cardiovascular Pharmacology|April 1, 1992
Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effectF Bulens, L Nelles, N Van den Panhuyzen, et al.The Journal of Biological Chemistry|August 9, 1996
Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein associationP Holvoet, Z Zhao, E Deridder, et al.Thrombosis and Haemostasis|January 23, 1992
An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PAP J Declerck, L Van Keer, M Verstreken, et al.Pageof 61